Repost, $LLBO FULL DD REPORT- EVERYTHING YOU NE
Post# of 29735
Posted On: 03/17/2015 8:18:28 AM
Repost,
$LLBO FULL DD REPORT- EVERYTHING YOU NEED
51.06% of Monday's beautiful trading volume composed of aproximately 60 MILLION shares shorted...
Friday's Short Volume (some of which still remains uncovered)- : 57.5 MILLION SHARES
OTC SHORT REPORT LINK : http://otcshortreport.com/index.php?index=LLBO#.VQeb5V6LQds
The only reason we didn't close up atleast 50% is due to that massive shorting at the end. I'd estimate 90% of the sells Monday were directly due to shorters.
ARE THESE GUYS FRICKING NUTS LMAO?? MASSIVE SHORT SQUEEZE COMING...THESE GUYS HAVE TO COVER... BUYING PRESSURE + SHORT SQUEEZE = COPPER-SILVER LAND
1) Stanford University Canary Center for Early Cancer Detection has pledged $187,000 to help fund the equipment for the trials at El Camino Hospital.
2 )Detected, a documentary movie about the journey to market of the iTBra™ was commissioned and paid for by Cisco Systems and will premiere at the SxSW Technology and Film Festival in Austin Texas next week, 3/16.
LINK TO AMAZING DETECTED TRAILER:: http://newsroom.cisco.com/video-content?type=...Id=1611072
LINK TO CISCO TWEETS ABOUT CIRCADIA AND THE MOVIE DETECTED (470K FOLLOWERS):
https://twitter.com/Cisco/status/577511348424167424
https://twitter.com/detectedmovie/status/577541555449364480
https://twitter.com/Cisco/status/577546373572239360
-4 DOCTORS WITH OUTSTANDING CREDENTIALS HAVE WORKED TO DEVELOPED THIS REVOLUTIONARY PRODUCT! (STANFORD GRAD, TOP 1% SURGEON IN THE WORLD)
LINK: CIRCADIA'S RESEARCH AND DEVELOPMENT TEAM: http://cyrcadiahealth.com/medical-advisory-board/
CYRCADIA BREAST-CANCER PREVENTION DEVICE RESULTS:
CLINICAL TRIALS:
Over 500 women tested in previous clinical trials achieved promising results in sensitivity, specificity and accuracy at 87% correlation to cancer, when compared to mammography’s 83% correlation. The studies also indicated improved outcomes for the Cyrcadia Health solution in difficult to image (dense breast tissue) patient populations. Cyrcadia Health is preparing for a multi-site final validation clinical study to be conducted in leading US and Asia cancer hospitals in late 2014. Cyrcadia Health intends to show equal to improved results to mammography in the general population with improved results over todays “gold standards” in the dense tissue population, which entails over 60% of all women under, and 40% over the age of 40. Our comfortable, non-compressive and non-irradiative approach will help to populate a global “big data” core library on phenotype/genotype, and demographic variables contributing to the state of breast cancer on a worldwide basis.
4% MORE EFFECTIVE THAN THE MODERN DAY TREATMENT + COST EFFECTIVE AND EARLY PREVENTION BENEFITS
MEDICAL ECONOMICS:
The Cyrcadia Health solution is a cost effective system that through early screening and detection can improve patient outcomes, reduce healthcare costs, improve surgical decision processes, and is a patient-friendly solution for breast screening.
FLEXTRONICS IS INVESTED IN CYRCADIA'S REVOLUTIONARY PRODUCT ($7BILLION DOLLAR INVESTMENT FIRM)
FLEX STOCK: http://investors.flextronics.com/faq.cfm
CYRCADIA HEALTH SOLUTIONS PARTNERS LINK: http://cyrcadiahealth.com/partners/
4) The ECH trial is slated for start before the end of April 2015. The trials are expected to be completed in four to 6 months. On completion Cyrcadia will obtain CE Marking allowing for sales and marketing outside of the USA. On completion of the trials Cyrcadia will be submitting a 510(k) to the FDA. Post clearance, marketing will begin in the USA.
5)It is interesting to note that Dr. Farrar at OSU will be the primary investigator for the trials conducted at OSU. Dr. Farrar headed the original "proof of concept" study that was conducted at OSU. Dr. Farrar published on the results of this study, commenting on the potential of this lifesaving technology that could assist in the early detection of breast tissue abnormalities and breast cancers.
DO YOU REALLY THINK THEY WONT PASS THE TRAILS LOL? NO WAY
$LLBO is Cyrcadia's largest shareholder, at approximately 40% via a 10 million dollar investment
LLBO owns 40% of Cyrcadia Health who’s product line is a device and software service that detects breast tissue abnormalities leading to health risk assessment and management including early breast cancer identification. Three clinical trials with over 650 participants have achieved proof of concept and superior outcomes when compared to other diagnostic protocols. Cyrcadia Health technology is exclusively licensed for development, manufacturing and marketing worldwide from Lifeline Biotechnologies, Inc (OTC Market: LLBO).
Cyrcadia Health is planning a final, limited clinical trial and a 510k device classification to validate the fourth generation of the FWS product. Cyrcadia Health is preparing to apply for a Euro CE Mark to market in the European Union and Asia Pacific markets.
On March 12 LLBO updates the meaningful activities for First Quarter of 2015: In 2008 Lifeline Biotechnologies exclusively licensed its First Warning Systems technology to First Warning Systems, Inc., (now called Cyrcadia Health) via a revenue royalty license of its patented, circadian rhythm based, pattern recognition technology. Three rounds of proof of concept trials were conducted and validated by the foremost pattern recognition engineers in the world (the Engineers at Nanyang Technological University in Singapore).
RECENT NEWS:http://finance.yahoo.com/news/lifeline-biotechnologies-llbo-q1-2015-171609507.html
]]
BARCHART INDICATOR'S OPINION (100% BUY SHORT,MEDIUM AND LONG TERM): http://www.barchart.com/opinions/stocks/LLBO
BARCHART TRADER'S CHEAT SHEET: http://www.barchart.com/cheatsheet.php?sym=LLBO
BREAK .0072 AND WERE HEADING TO SILVER]
LLBO Share Structure: http://www.otcmarkets.com/stock/LLBO/profile
650m FLOAT
HOLY....LOOK AT THE ACCUM/DISP LINE: http://stockcharts.com/h-sc/ui?s=LLBO&p=W...9569738426
KNOW WHAT U OWN SO YOU CAN MAKE INFORMED FINANCIAL DECISIONS. LOAD AND HOLD IMO
$LLBO FULL DD REPORT- EVERYTHING YOU NEED
51.06% of Monday's beautiful trading volume composed of aproximately 60 MILLION shares shorted...
Friday's Short Volume (some of which still remains uncovered)- : 57.5 MILLION SHARES
OTC SHORT REPORT LINK : http://otcshortreport.com/index.php?index=LLBO#.VQeb5V6LQds
The only reason we didn't close up atleast 50% is due to that massive shorting at the end. I'd estimate 90% of the sells Monday were directly due to shorters.
ARE THESE GUYS FRICKING NUTS LMAO?? MASSIVE SHORT SQUEEZE COMING...THESE GUYS HAVE TO COVER... BUYING PRESSURE + SHORT SQUEEZE = COPPER-SILVER LAND
1) Stanford University Canary Center for Early Cancer Detection has pledged $187,000 to help fund the equipment for the trials at El Camino Hospital.
2 )Detected, a documentary movie about the journey to market of the iTBra™ was commissioned and paid for by Cisco Systems and will premiere at the SxSW Technology and Film Festival in Austin Texas next week, 3/16.
LINK TO AMAZING DETECTED TRAILER:: http://newsroom.cisco.com/video-content?type=...Id=1611072
LINK TO CISCO TWEETS ABOUT CIRCADIA AND THE MOVIE DETECTED (470K FOLLOWERS):
https://twitter.com/Cisco/status/577511348424167424
https://twitter.com/detectedmovie/status/577541555449364480
https://twitter.com/Cisco/status/577546373572239360
-4 DOCTORS WITH OUTSTANDING CREDENTIALS HAVE WORKED TO DEVELOPED THIS REVOLUTIONARY PRODUCT! (STANFORD GRAD, TOP 1% SURGEON IN THE WORLD)
LINK: CIRCADIA'S RESEARCH AND DEVELOPMENT TEAM: http://cyrcadiahealth.com/medical-advisory-board/
CYRCADIA BREAST-CANCER PREVENTION DEVICE RESULTS:
CLINICAL TRIALS:
Over 500 women tested in previous clinical trials achieved promising results in sensitivity, specificity and accuracy at 87% correlation to cancer, when compared to mammography’s 83% correlation. The studies also indicated improved outcomes for the Cyrcadia Health solution in difficult to image (dense breast tissue) patient populations. Cyrcadia Health is preparing for a multi-site final validation clinical study to be conducted in leading US and Asia cancer hospitals in late 2014. Cyrcadia Health intends to show equal to improved results to mammography in the general population with improved results over todays “gold standards” in the dense tissue population, which entails over 60% of all women under, and 40% over the age of 40. Our comfortable, non-compressive and non-irradiative approach will help to populate a global “big data” core library on phenotype/genotype, and demographic variables contributing to the state of breast cancer on a worldwide basis.
4% MORE EFFECTIVE THAN THE MODERN DAY TREATMENT + COST EFFECTIVE AND EARLY PREVENTION BENEFITS
MEDICAL ECONOMICS:
The Cyrcadia Health solution is a cost effective system that through early screening and detection can improve patient outcomes, reduce healthcare costs, improve surgical decision processes, and is a patient-friendly solution for breast screening.
FLEXTRONICS IS INVESTED IN CYRCADIA'S REVOLUTIONARY PRODUCT ($7BILLION DOLLAR INVESTMENT FIRM)
FLEX STOCK: http://investors.flextronics.com/faq.cfm
CYRCADIA HEALTH SOLUTIONS PARTNERS LINK: http://cyrcadiahealth.com/partners/
4) The ECH trial is slated for start before the end of April 2015. The trials are expected to be completed in four to 6 months. On completion Cyrcadia will obtain CE Marking allowing for sales and marketing outside of the USA. On completion of the trials Cyrcadia will be submitting a 510(k) to the FDA. Post clearance, marketing will begin in the USA.
5)It is interesting to note that Dr. Farrar at OSU will be the primary investigator for the trials conducted at OSU. Dr. Farrar headed the original "proof of concept" study that was conducted at OSU. Dr. Farrar published on the results of this study, commenting on the potential of this lifesaving technology that could assist in the early detection of breast tissue abnormalities and breast cancers.
DO YOU REALLY THINK THEY WONT PASS THE TRAILS LOL? NO WAY
$LLBO is Cyrcadia's largest shareholder, at approximately 40% via a 10 million dollar investment
LLBO owns 40% of Cyrcadia Health who’s product line is a device and software service that detects breast tissue abnormalities leading to health risk assessment and management including early breast cancer identification. Three clinical trials with over 650 participants have achieved proof of concept and superior outcomes when compared to other diagnostic protocols. Cyrcadia Health technology is exclusively licensed for development, manufacturing and marketing worldwide from Lifeline Biotechnologies, Inc (OTC Market: LLBO).
Cyrcadia Health is planning a final, limited clinical trial and a 510k device classification to validate the fourth generation of the FWS product. Cyrcadia Health is preparing to apply for a Euro CE Mark to market in the European Union and Asia Pacific markets.
On March 12 LLBO updates the meaningful activities for First Quarter of 2015: In 2008 Lifeline Biotechnologies exclusively licensed its First Warning Systems technology to First Warning Systems, Inc., (now called Cyrcadia Health) via a revenue royalty license of its patented, circadian rhythm based, pattern recognition technology. Three rounds of proof of concept trials were conducted and validated by the foremost pattern recognition engineers in the world (the Engineers at Nanyang Technological University in Singapore).
RECENT NEWS:http://finance.yahoo.com/news/lifeline-biotechnologies-llbo-q1-2015-171609507.html
]]
BARCHART INDICATOR'S OPINION (100% BUY SHORT,MEDIUM AND LONG TERM): http://www.barchart.com/opinions/stocks/LLBO
BARCHART TRADER'S CHEAT SHEET: http://www.barchart.com/cheatsheet.php?sym=LLBO
BREAK .0072 AND WERE HEADING TO SILVER]
LLBO Share Structure: http://www.otcmarkets.com/stock/LLBO/profile
650m FLOAT
HOLY....LOOK AT THE ACCUM/DISP LINE: http://stockcharts.com/h-sc/ui?s=LLBO&p=W...9569738426
KNOW WHAT U OWN SO YOU CAN MAKE INFORMED FINANCIAL DECISIONS. LOAD AND HOLD IMO
(0)
(0)
I'm in it to win it!
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
Scroll down for more posts ▼